Abnormal Development - Fetal Growth Restriction: Difference between revisions

Revision as of 10:16, 21 April 2013

Introduction

Relative fetal sizes

The fetal period (weeks 9 to 37) is about four times the length of the embryonic period and is a time of extensive growth in size and mass as well as ongoing differentiation of organ systems established in the embryonic period. Clinically this period is generally described as the Second Trimester and Third Trimester. Many of the critical measurements of growth are now carried out by ultrasound and this period ends at birth. The term "Fetal Growth Restriction" (FGR) or intrauterine growth restriction (IUGR) are used to describe when the fetus does not reach full growth potential. This is usually determined by clinical sonography calculations of fetal weight, fetal size, or symmetry.

Historic Embryology
1940 Fetus Physiology
Carnegie Fetal: 95 \| 96 \| 142 \| 145 \| 184 \| 211 \| 217 \| 300 \| 362 \| 448 \| 449 \| 538 \| 590 \| 607 \| 625 \| 662 \| 693 \| 847 \| 858 \| 922 \| 928 \| 948 \| 972 \| 1318 \| 1388 \| 1455 \| 1591 \| 1597b \| 1656 \| 1686 \| 2250a \| 2250b \| 3990 \| 5652 \| 6581 \| 7218

Some Recent Findings

Fetus (week 10)

A randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation-a feasibility study^[1] "Women presenting with reduced fetal movements (RFM) in the third trimester are at increased risk of stillbirth or fetal growth restriction. These outcomes after RFM are related to smaller fetal size on ultrasound scan, oligohydramnios and lower human placental lactogen (hPL) in maternal serum. We performed this study to address whether a randomised controlled trial (RCT) of the management of RFM was feasible with regard to: i) maternal recruitment and retention ii) patient acceptability, iii) adherence to protocol. Additionally, we aimed to confirm the prevalence of poor perinatal outcomes defined as: stillbirth, birthweight <10th centile, umbilical arterial pH <7.1 or unexpected admission to the neonatal intensive care unit. ...An RCT of management of RFM is feasible with a low rate of attrition. Investigations decrease maternal anxiety. Participants in the intensive group were more likely to have IOL for RFM. Further work is required to determine the likely level of intervention in the standard care arm in multiple centres, to develop additional placental biomarkers and to confirm that the composite outcome is valid.Trial registration ISRCTN07944306."

Reading

Human Embryology (3rd ed.) Larson Chapter 15: Fetal development and the Fetus as Patient p481-499
The Developing Human: Clinically Oriented Embryology (8th ed.) Moore and Persaud Chapter 6: The Fetal Period: Ninth Week to Birth
Color Atlas of Clinical Embryology (2nd ed.) Moore, Persaud and Shiota Chapter 3: 9th to 38th weeks of human development p50-68

‎‎Fetal Development

Page | Play

Fetal length and weight change

Second Trimester

Fetus - second trimester
(ultrasound)

Second Trimester
Week 12 - CRL 85 mm, femur length 15 mm, biparietal diameter 25 mm.

Begin by working through the features present in the early 10 week female fetus. Then look in detail at the head development in a 12 week fetus.

**10 Week Fetus** *head images*

Then look in detail at the head development in a 12 week fetus showing both forms of ossification in the skull.

**12 Week Fetus** *head images*

Fetal Head Growth

Second and third trimesters
Second trimester

Third Trimester

Fetus - third trimester
(historic image)

Third trimester Crown-Rump Length

Vibration acoustically of maternal abdominal wall induces startle respone in fetus.
Month 7 - respiratory bronchioles proliferate and end in alveolar ducts and sacs.
Week 37 to 38 Birth.

Links: Third Trimester

References

↑ <pubmed>23590451</pubmed>

Journals

Seminars in Fetal & Neonatal Medicine

Reviews

Articles

Search PubMed

Search Pubmed: Fetal Growth Restriction

Glossary Links

Glossary: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Numbers | Symbols | Term Link

Cite this page: Hill, M.A. (2024, May 8) Embryology Abnormal Development - Fetal Growth Restriction. Retrieved from https://embryology.med.unsw.edu.au/embryology/index.php/Abnormal_Development_-_Fetal_Growth_Restriction

What Links Here?

[PMID23590451-1] <pubmed>23590451</pubmed>

[1]

@@ Line 17: / Line 17: @@
 |-bgcolor="F5FAFF"
 |
-* <ref><pubmed></pubmed></ref>
+* A '''randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation-a feasibility study'''<ref name=PMID23590451><pubmed>23590451</pubmed></ref> "Women presenting with reduced fetal movements (RFM) in the third trimester are at increased risk of stillbirth or fetal growth restriction. These outcomes after RFM are related to smaller fetal size on ultrasound scan, oligohydramnios and lower human placental lactogen (hPL) in maternal serum. We performed this study to address whether a randomised controlled trial (RCT) of the management of RFM was feasible with regard to: i) maternal recruitment and retention ii) patient acceptability, iii) adherence to protocol. Additionally, we aimed to confirm the prevalence of poor perinatal outcomes defined as: stillbirth, birthweight <10th centile, umbilical arterial pH <7.1 or unexpected admission to the neonatal intensive care unit. ...An RCT of management of RFM is feasible with a low rate of attrition. Investigations decrease maternal anxiety. Participants in the intensive group were more likely to have IOL for RFM. Further work is required to determine the likely level of intervention in the standard care arm in multiple centres, to develop additional placental biomarkers and to confirm that the composite outcome is valid.Trial registration ISRCTN07944306."
 |}